A really inspiring development in the digital therapeutics sphere with the FDA approving a video based game as a prescription treatment for ADHD. It will be really interesting to see, especially in a post-Covid world, how tech solutions are able to help us in more diverse ways - and how both big tech and more traditional healthcare companies will adjust and potentially collaborate.
| less than a minute read
FDA approve video game as a clinical treatment
Get in touch
Get in touch
Akili today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for EndeavorRxTM (AKL-T01) as a prescription treatment for children with attention deficit hyperactivity disorder (ADHD). Delivered through a captivating video game experience, EndeavorRx is indicated to improve attention function as measured by computer-based testing in children ages 8-12 years old with primarily inattentive or combined-type ADHD, who have a demonstrated attention issue.
Get in touch
Get in touch
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-03-19-17-30-27-593-65f9cbb3bf22b75d160b136f.jpg)
Welcome to ‘What every Life Sciences lawyer needs (Commercial Contracts)’, a series in which DLA Piper’s Life Sciences Commercial...
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-04-18-09-16-42-370-6620e4fa7330266071d4ac1d.jpg)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Document/2024-04-15-09-40-05-618-LS_marzec_2024_EN_thumbnail_1.png)
/Passle/596df0e43d947619ec025f26/MediaLibrary/Video/Transcoded/2024-04-10-12-51-54-366-CST0671_Inspirational_Women_in_Life_Sciences_Lisa_L/thumbnails/2024-04-10-12-51-54-366-CST0671_Inspirational_Women_in_Life_Sciences_Lisa_L_HLS_Video_2M_1080P_00002.png)
/Passle/596df0e43d947619ec025f26/SearchServiceImages/2024-04-09-08-55-13-350-66150271e03ff7b7beb1f514.jpg)
